Rhenium-186 NanoLiposome
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Rhenium-186 NanoLiposome, covering 2025-03-26 to 2025-08-01. Get the full timeline:
Most recent: Clinical Trial Update: Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases [Phase 1]